Tagged dukenus
Hyris Chalk Up Another Success Fighting COVID19, Providing Canadian Researchers and Medical Specialists With a New Test to Detect T-Cell Immune Response to SARS-CoV-2
Hyris developed a rapid T-Cell test to track patients' immunity levels to SARS-CoV-2 for global clinical and research use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the power of the renowned HYRIS bCUBE™ and the whole Hyris SystemTM. This disruptive platform enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.
Read More
Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical
Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.
Read More